The Relationship between Lifestyle, Mental Health, and Loneliness in the Elderly during the COVID-19 Pandemic.

The Relationship between Lifestyle, Mental Health, and Loneliness in the Elderly during the COVID-19 Pandemic.

Publication date: Apr 23, 2024

The study focused on examining the relationship between well-being and various psychological factors such as loneliness, anxiety, depression, and stress, whilst also considering changes in lifestyle. A total of 108 elderly participants, with an average age of 70. 38 years, were enrolled in this quantitative cross-sectional study. The research employed a battery of assessment tools including a Sociodemographic Data Questionnaire, Mini-Mental State Examination, Positive Mental Health Scale, Stress Perception Scale, Geriatric Anxiety Inventory, Geriatric Depression Scale (reduced version), Loneliness Scale, and International Physical Activity Questionnaire. Descriptive analysis was conducted in order to understand the distribution of scores across these variables, followed by the categorization of participants based on the reported alterations in eating and physical activity behaviors. Correlations between variables were assessed using Spearman correlation and an EBIC-LASSO network analysis. The findings indicated a potential detriment to the well-being of elderly individuals practicing social distancing, evidenced by heightened symptoms of loneliness, depression, anxiety, and stress, alongside the reported changes in dietary patterns and physical activity. The study underscores the importance of understanding the pandemic’s impact on the well-being of older adults and advocates for longitudinal investigations to delineate the evolving effects of social distancing measures across different phases of the pandemic.

Open Access PDF

Concepts Keywords
Basel aging
Eating COVID-19
Elderly health promotion
Healthcare loneliness
Sociodemographic mental health

Semantics

Type Source Name
disease MESH Lifestyle
disease MESH Loneliness
disease MESH COVID-19 Pandemic
drug DRUGBANK Ribostamycin
drug DRUGBANK Coenzyme M
disease VO organization
disease MESH complications
disease IDO process
disease MESH viral infections
disease MESH chronic conditions
disease MESH non communicable diseases
disease MESH cardiovascular disease
disease MESH obesity
disease MESH cancer
pathway REACTOME Immune System
disease MESH infections
drug DRUGBANK Isoxaflutole
disease VO population
disease MESH emotional distress
disease MESH anxiety disorders
disease MESH cognitive decline
disease MESH Alzheimer’s disease
disease VO effective
disease VO document
disease MESH dementia
disease VO frequency
drug DRUGBANK Methionine
drug DRUGBANK Albendazole
disease MESH retirement
disease IDO symptom
disease IDO infection
disease MESH multiple sclerosis
disease MESH inflammation
disease IDO intervention
drug DRUGBANK Trestolone
disease MESH Influenza
drug DRUGBANK Coal tar
drug DRUGBANK Efavirenz
disease VO Canada
disease MESH mental disorders
drug DRUGBANK Serine
disease MESH Uncertainty
drug DRUGBANK Modafinil

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *